Peroxisome proliferator-activated receptor-γ activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis

Abstract

To study the expression of peroxisome proliferator-activated receptor-γ(PPAR-γ) in lung cancer cells, and to testify if the PPAR-γ agonists can inhibit human lung cancer cell growth through induction of apoptosis, PPAR-γ was detected in two lung cancer cell lines by RT-PCR and immunohistochemistry, the inhibition of human lung cancer cell growth was investigated by MTT and cell counts, and the apoptosis was assessed by TUNEL. The results showed that: (1) PPAR-γ expressed on two lung cancer cell lines; (2) PPAR-γ activated by ligands could inhibit human lung cancer cell growth remarkably; (3) PPAR-γ agonists could induce apoptosis to inhibit lung cancer cell growth. It was concluded that PPAR-γ expressed in lung cancer cell can be activated by ligands and can inhibit lung cancer cell growth through induction of apoptosis.

Keywords

PPAR-γ / ligands / lung cancer cell / apoptosis

References

[1] FajasL, DebrilM B, AuwerxJ, et al. . Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol, 2001, 27(1): 1-1

[2] TsubouchiY, SanoH, KawahitoY, et al. . Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun, 2000, 270(2): 400-400

[3] EiblG, WenteM N, ReberH A, et al. . Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun, 2001, 287(2): 522-522

[4] JiangW G, RedernA, BryceR P, et al. . Peroxisome proliferator activated receptor-gamma (PPAR-gamma) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids, 2000, 62(2): 119-119

[5] KitamuraS, MiyazakiY, ShinomuraY, et al. . Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res, 1999, 90(1): 75-75

[6] TheocharisS, KanelliH, PolitiE, et al. . Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade. Lung Cancer, 2002, 36(3): 249-249

[7] WijnhovenB P, LindstedtE W, AbbouM, et al. . Molecular genetic analysis of the von Hippel-Lindau and human peroxisome proliferator-activated receptor gamma tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction. Int J Cancer, 2001, 94(6): 891-891

[8] WoodI. Pro-inflammatory mechanisms of a nonsteroidal anti-inflammatory drug. Trends Endocrinol Metab, 2002, 13(2): 53-53

[9] SatohT, ToyodaM, HoshinoH, et al. . Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Oncogene, 2002, 21(14): 2171-2171

[10] InoueK, KawahitoY, TsubouchiY, et al. . Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Anticancer Res, 2001, 21(4A): 2471-2471